rs185609509
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_012120.3(CD2AP):c.1417+19C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,604,408 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00015 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00019 ( 2 hom. )
Consequence
CD2AP
NM_012120.3 intron
NM_012120.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.490
Publications
0 publications found
Genes affected
CD2AP (HGNC:14258): (CD2 associated protein) This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. [provided by RefSeq, Jul 2008]
CD2AP Gene-Disease associations (from GenCC):
- focal segmental glomerulosclerosis 3, susceptibility toInheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial idiopathic steroid-resistant nephrotic syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-47599462-C-T is Benign according to our data. Variant chr6-47599462-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 260184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CD2AP | NM_012120.3 | c.1417+19C>T | intron_variant | Intron 13 of 17 | ENST00000359314.5 | NP_036252.1 | ||
| CD2AP | XM_005248976.2 | c.1405+19C>T | intron_variant | Intron 13 of 17 | XP_005249033.1 | |||
| CD2AP | XM_011514449.3 | c.1270+19C>T | intron_variant | Intron 12 of 16 | XP_011512751.1 | |||
| CD2AP | XM_017010641.2 | c.1417+19C>T | intron_variant | Intron 13 of 13 | XP_016866130.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CD2AP | ENST00000359314.5 | c.1417+19C>T | intron_variant | Intron 13 of 17 | 1 | NM_012120.3 | ENSP00000352264.5 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 23AN: 151000Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
23
AN:
151000
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000359 AC: 88AN: 245282 AF XY: 0.000377 show subpopulations
GnomAD2 exomes
AF:
AC:
88
AN:
245282
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000191 AC: 277AN: 1453296Hom.: 2 Cov.: 30 AF XY: 0.000199 AC XY: 144AN XY: 723088 show subpopulations
GnomAD4 exome
AF:
AC:
277
AN:
1453296
Hom.:
Cov.:
30
AF XY:
AC XY:
144
AN XY:
723088
show subpopulations
African (AFR)
AF:
AC:
2
AN:
33068
American (AMR)
AF:
AC:
0
AN:
44324
Ashkenazi Jewish (ASJ)
AF:
AC:
204
AN:
25954
East Asian (EAS)
AF:
AC:
1
AN:
39298
South Asian (SAS)
AF:
AC:
3
AN:
85440
European-Finnish (FIN)
AF:
AC:
0
AN:
53232
Middle Eastern (MID)
AF:
AC:
0
AN:
5742
European-Non Finnish (NFE)
AF:
AC:
42
AN:
1106244
Other (OTH)
AF:
AC:
25
AN:
59994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
13
26
39
52
65
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000152 AC: 23AN: 151112Hom.: 0 Cov.: 32 AF XY: 0.000149 AC XY: 11AN XY: 73732 show subpopulations
GnomAD4 genome
AF:
AC:
23
AN:
151112
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
73732
show subpopulations
African (AFR)
AF:
AC:
2
AN:
41116
American (AMR)
AF:
AC:
1
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
AC:
16
AN:
3464
East Asian (EAS)
AF:
AC:
1
AN:
5138
South Asian (SAS)
AF:
AC:
0
AN:
4802
European-Finnish (FIN)
AF:
AC:
0
AN:
10332
Middle Eastern (MID)
AF:
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
AC:
2
AN:
67808
Other (OTH)
AF:
AC:
1
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Focal segmental glomerulosclerosis 3, susceptibility to Benign:1
Feb 19, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
May 29, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.